Trinity Biotech Plc (TRIB) Gross Profit Margin starting from the fourth quarter 2025 to fourth quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Trinity Biotech Plc  (NASDAQ: TRIB)


Trinity Biotech Plc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TRIB Gross Profit Margin (Dec 31 2025)
Q4 		0
Q3 		0
Q2 		0
Q1 		(Dec 31 2024)
Q4
Y / Y Revenue Change -28.87 %
Seq. Revenue Change -
Revenue In Millions $43.79
Gross Profit Margin 38.57 %
Gross Profit Margin Total Ranking # 2322
Gross Profit In Millions $16.89
Y / Y Gross Profit Change -21.24 %
Seq. Gross Profit Change -


Commenting fourth quarter 2025 Gross Profit Margin



Observing fourth quarter 2025 results within In Vitro & In Vivo Diagnostic Substances industry 6 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 2322.
Learn about Gross Margin
TRIB's Gross Profit Margin fourth quarter 2025 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 7
Healthcare Sector # 384
Overall # 2310

Gross Profit Margin Statistics
High Average Low
47.64 % 38.82 % 29.48 %
(Dec 31 2020)   (Dec 31 2022)


TRIB Gross Income Trends • More of TRIB's Profitabilty Ratios • TRIB Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
TRIB's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
TRIB's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for TRIB's Competitors
Gross Profit Margin Profit Margin for Trinity Biotech Plc's Suppliers
Gross Profit Margin Profit Margin for TRIB's Customers

You may also want to know
TRIB's Annual Growth Rates TRIB's Profitability Ratios TRIB's Asset Turnover Ratio TRIB's Dividend Growth
TRIB's Roe TRIB's Valuation Ratios TRIB's Financial Strength Ratios TRIB's Gross Profit Growth
TRIB's Roa TRIB's Inventory Turnover Ratio TRIB's Growth Rates TRIB's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2025, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginDec 31 2025 MRQ Gross ProfitDec 31 2025 MRQ Revenue
Myriad Genetics Inc   69.64 %$ 146.800  Millions$ 210.800  Millions
Idexx Laboratories Inc  60.26 %$ 658.114  Millions$ 1,092.114  Millions
Lantheus Holdings Inc   59.20 %$ 240.875  Millions$ 406.875  Millions
Neogen Corporation  47.48 %$ 106.684  Millions$ 224.684  Millions
Quidelortho Corp  44.28 %$ 320.400  Millions$ 723.600  Millions
Insight Molecular Diagnostics Inc   43.55 %$ 0.496  Millions$ 1.139  Millions
Trinity Biotech Plc  38.57 %$ 16.887  Millions$ 43.785  Millions
Immucell Corporation  38.44 %$ 2.910  Millions$ 7.570  Millions
Alpha Teknova Inc   32.49 %$ 3.244  Millions$ 9.984  Millions
Aspira Women s Health inc   24.21 %$ 1.438  Millions$ 5.939  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.